[1]李 玲a,罗雅文a,何 霞a,等.子宫内膜癌患者BMI与血清HE4,CA125联合检测的诊断价值[J].现代检验医学杂志,2018,33(05):91-94.[doi:10.3969/j.issn.1671-7414.2018.05.024]
　LI Linga,LUO Ya-wena,HE Xiaa,et al.Diagnostic Value of Combined Detection of Body Mass Index and Serum HE4,CA125 in Patients with Endometrial Carcinoma[J].Journal of Modern Laboratory Medicine,2018,33(05):91-94.[doi:10.3969/j.issn.1671-7414.2018.05.024]
点击复制

子宫内膜癌患者BMI与血清HE4,CA125联合检测的诊断价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年05期
页码:
91-94
栏目:
论著
出版日期:
2018-11-18

文章信息/Info

Title:
Diagnostic Value of Combined Detection of Body Mass Index and Serum HE4,CA125 in Patients with Endometrial Carcinoma
文章编号:
1671-7414(2018)05-091-04
作者:
李 玲a; 罗雅文a; 何 霞a; 羊 建a; 文 勃b
雅安市人民医院a.检验科; b.呼吸儿科,四川雅安 625000
Author(s):
LI Linga; LUO Ya-wena; HE Xiaa; YANG Jiana; WEN Bob
a.Department of Laboratory Medicine; b.Department of Respiratory Pediatrics,Ya'an People's Hospital,Sichuan Ya'an 625000,China
关键词:
子宫内膜癌;  人附睾蛋白4;  糖类抗原125;  身体质量指数;  诊断价值
分类号:
R737.33; R730.43
DOI:
10.3969/j.issn.1671-7414.2018.05.024
文献标志码:
A
摘要:
目的 评价身体质量指数(body mass index,BMI)与人睾分泌蛋白(human epididymis protein4,HE4)、糖类抗原125(carbohydrate antigen,CA125)联合检测在子宫内膜癌诊断中的价值。方法 选择2016年3月～2017年6月住院拟行手术治疗子宫内膜癌患者81例,子宫内膜良性病变患者70例; 采集所有研究对象的身高、体重资料,计算BMI; 采用电化学发光法检测血清HE4和CA125含量水平,并对结果进行分析。结果 子宫内膜癌组患者血清HE4(Z=-17.613),CA125(Z=-5.327)含量水平,以及BMI(t=2.264)较子宫内膜良性病变组明显升高,差异有统计学意义(均P<0.05); 子宫内膜癌组肥胖率(49.4%)高于内膜良性病变组(30.0%)(χ2=5.859,P=0.015); 在BMI<28.0 kg/m2和BMI≥28.0 kg/m2 水平子宫内膜癌组HE4含量均高于内膜良性病变组(Z=-8.026,-12.154,均P<0.05),而CA125仅在BMI<28.0 kg/m2时子宫内膜癌组高于内膜良性病变组(Z=-7.178,P<0.05); ROC曲线分析显示,HE4,CA125和BMI单独检测的曲线下面积分别为0.795,0.692和0.648; 而三项联合检测的曲线下面积最大,为0.841。三项联合检测的敏感度和特异度分别为0.75,0.79,Youden指数为0.54; 均优于各指标单项检测时的诊断效能。结论BMI与血清HE4,CA125联合诊断子宫内膜癌效能优于单项检测。
Abstract:
Objective To evaluate the value of combinationdetection of BMI and HE4,CA125 in the diagnosis of endometrial carcinoma.Methods 81 patients with endometrial cancer and 70 patients with endometrial benign lesion were enrolled in this study.The height and weight of all the parients were collected,then the BMI of all the patients were accounted.The levels of CA125 and HE4 were detected by electrochemiluminescence,and the results were analyzed.Results The level of HE4(Z=-17.613),CA125(Z=-5.327)and BMI(t=2.264)in the patients with endometrial cancer group were significantly increased comparing to endometrium benign lesion group(all P<0.05).The obesity rate of endometrial carcinoma group(49.4%)was significantly higher than that of endometrial benign lesion group(χ2=5.859,P=0.015).Further subgroup analysis according to BMI(BMI <28.0 kg/m2 versus BMI ≥28.0 kg/m2)revealed significant differences between endometrial cancer group and endometrial benign lesion group for HE4 levels(Z=-8.026,-12.154,all P<0.05),while serum CA-125 levels were significantly different only in BMI <28.0 kg/m2(Z=-7.178,P<0.05).ROC curveanalysis showed that the AUC of HE4,CA125 and BMI was 0.795,0.692 and 0.648 respectively,while the AUC of combination detection of HE4,CA125 and BMI wasthe largest,which was 0.841.The sensitivity and specificity of combination detection were 0.75 and 0.79,and the Youden index was 0.54,which was betterthan the diagnostic efficiency of the single item test.ConclusionThe combination detection of BMI and HE4,CA125 in diagnosis of endometrial carcinoma is superior to single detection.

参考文献/References:

[1] Ahmedin J,Freddie B,Melissa M,et al.Global cancer statidtics[J].CA Cancer J Clin,2011,61(2):69-90.
[2] Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int.JCancer,2015,136(5):E359-E386.
[3] 邢瑞青,吴永昌,陈慧昱,等.血清CA125,HE4及ROMA指数对卵巢癌诊断价值的临床研究[J].现代检验医学杂志,2016,31(6):37-40,43.
Xing RQ,Wu YC,Chen HY,et al.Diognostic value of serum CA125,HE4and ROMA index in patients with ovarian cancer[J].J Mod Lab Med,2016,31(6):37-40,43.
[4] Zanotti L,Bignotti E,Calza S,et al.Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome[J].Clin Chem Lab Med,2012,50(12):2189-2198.
[5] 中华人民共和国国家卫生与计划生育委员会.WS/TA28-2013成人体重判定[S].北京:中国标准出版社,2013.
National Health and Family Planning Commission of the People's Republic of China.WS/TA28-2013.Adult weight detemination[S].Beijing:China Standard Publishing House,2013.
[6] 刘肖英.宫腔镜下分段诊刮术对子宫内膜癌的诊断价值[J].齐齐哈尔医学院学报,2016,37(2):177-179.
Liu XY.Clinical value of fractional curettage in diagnosis of endormetrial cancer under hysterossopy[J].Journal of Qiqihar University of Medicine,2016,37(2):177-179.
[7] Nikolaou M,Kourea HP,Tzelepi V,et al.The prognostic role of preoperative serum CA 125 levels in patients with endometrial carcinoma[J].J BUON,2014,19(1):198-202.
[8] Modarres-Gilani M,Vaezi M,Shariat M,et al.The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma[J].Cancer Biomark,2017,20(2):135-141.
[9] Dewan R,Dewan A,Hare S,et al.Diagnostic performance of serum human epididymis protein 4 in endometrial carcinoma:a pilot study[J].J Clin Diagn Res,2017,11(7):XC01-XC05.
[10] Presl J,Ovesna P,Novotny Z,et al.Importance of preoperativeknowledge of the biomarker HE4 in early-stage endometrial cancer regarding surgical management[J].Anticancer Res,2017,37(5):2697-2702.
[11] Abbink K,Zusterzeel PL,Geurts-Moesot AJ,et al.HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients[J].Tumour Biol,2018,40(2):1010428318757103.
[12] Chen Y,Ren YL,Li N,et al.Serum human epididymis protein 4 vs carbohydrate antigen 125 and their combination for endometrial cancer diagnosis:a meta-analysis[J].Eur Rev Med Pharmacol Sci,2016,20(10):1974-1985.

相似文献/References:

[1]邢瑞青,吴永昌,陈慧昱,等.血清CA125,HE4及ROMA指数对卵巢癌诊断价值的临床研究[J].现代检验医学杂志,2016,31(06):37.[doi:10.3969/j.issn.1671-7414.2016.06.010]
　XING Rui-qing,WU Yong-chang,CHEN Hui-yu,et al.Diagnostic Value of Serum CA125,HE4 and ROMA Index in Patients with Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2016,31(05):37.[doi:10.3969/j.issn.1671-7414.2016.06.010]
[2]季红兵,唐芹芳,陈思聪,等.血清肿瘤标志物HE4对肺癌的诊断价值[J].现代检验医学杂志,2017,32(02):110.[doi:10.3969/j.issn.1671-7414.2017.02.030]
　JI Hong-bin,TANG Qin-fang,CHEN Si-cong,et al.Application of Serum HE4 in the Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2017,32(05):110.[doi:10.3969/j.issn.1671-7414.2017.02.030]
[3]李晓丽,胡陇娟.子宫内膜癌组织中长链非编码RNA ZEB1-AS1的表达与临床特征及对化疗药物耐药性研究[J].现代检验医学杂志,2019,34(04):35.[doi:10.3969/j.issn.1671-7414.2019.04.009]
　LI Xiao-li,HU Long-juan.Research on Expression and Clinical Characteristics of Long-Chain Non-Coding RNA ZEB1-AS1 in Endometrial Carcinoma and Resistance to Chemotherapy Drugs[J].Journal of Modern Laboratory Medicine,2019,34(05):35.[doi:10.3969/j.issn.1671-7414.2019.04.009]
[4]王娟,刘鑫,席稳燕.HMMR-AS1 在子宫内膜癌化疗耐药中的作用[J].现代检验医学杂志,2020,35(05):45.[doi:10.3969/j.issn.1671-7414.2020.05.012]
　WANG Juan,LIU Xin,XI Wen-yan.Effect of HMMR-AS1 on the Chemotherapy-Resistance of Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2020,35(05):45.[doi:10.3969/j.issn.1671-7414.2020.05.012]
[5]李功娟,张治洋,樊阳阳.FEZF1-AS1在子宫内膜癌中的表达及其与患者临床特征的相关性[J].现代检验医学杂志,2021,36(01):77.[doi:10.3969/j.issn.1671-7414.2021.01.020]
　LI Gong-juan,ZHANG Zhi-yang,FAN Yang-yang.Expression of FEZF1-AS1 in Endometrial Carcinoma and Its Correlation with Clinical Characteristics of Patients[J].Journal of Modern Laboratory Medicine,2021,36(05):77.[doi:10.3969/j.issn.1671-7414.2021.01.020]
[6]陈丽华,朱婕曼,刘玉凤,等.子宫内膜癌组织中血管紧张素~1-7及线粒体组装受体水平表达与临床病理特征的相关性[J].现代检验医学杂志,2021,36(02):24.[doi:doi:10.3969/j.issn.1671-7414.2021.02.006]
　CHEN Li-hua,ZHU Jie-man,LIU Yu-feng,et al.Correlation between the Expression of Angiotensin (1-7) and Mitochondrial Assembled Receptors and Clinicopathological Characteristics in Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2021,36(05):24.[doi:doi:10.3969/j.issn.1671-7414.2021.02.006]
[7]陈晓宇,曾庆维,陈红林,等.子宫内膜癌组织中miR-3188和mTOR表达量与预后的相关性研究[J].现代检验医学杂志,2021,36(06):17.[doi:10.3969/j.issn.1671-7414.2021.06.004]
　CHEN Xiao-yu,ZENG Qing-wei,CHEN Hong-lin,et al.Study on the Correlation between the Expression Levels of miR-3188 and mTOR in Endometrial Cancer and the Prognosis[J].Journal of Modern Laboratory Medicine,2021,36(05):17.[doi:10.3969/j.issn.1671-7414.2021.06.004]
[8]刘静雅,张海亮,李宝平,等.长链非编码 RNA SNHG1在子宫内膜癌中的表达及调控 PI3K/AKT信号通路的研究[J].现代检验医学杂志,2022,37(01):119.[doi:10.3969/j.issn.1671-7414.2022.01.024]
　LIU Jing-ya,ZHANG Hai-liang,LI Bao-ping,et al.Expression of Long Non-coding RNA SNHG1 in Endometrial Carcinoma and Its Regulation of PI3K/AKT Signaling Pathway[J].Journal of Modern Laboratory Medicine,2022,37(05):119.[doi:10.3969/j.issn.1671-7414.2022.01.024]
[9]彭 浩,张印星,谢 环.长链非编码RNA CDKN2BAS 在子宫内膜癌组织表达及其生物学功能研究[J].现代检验医学杂志,2023,38(03):92.[doi:10.3969/j.issn.1671-7414.2023.03.016]
　PENG Hao,ZHANG Yin-xing,XIE Huan.Expression and Biological Function of Long Non-coding RNA CDKN2BAS in Endometrial Carcinoma[J].Journal of Modern Laboratory Medicine,2023,38(05):92.[doi:10.3969/j.issn.1671-7414.2023.03.016]
[10]梁燕茹,郑 瑜,李 倩.子宫内膜癌患者术前血清apo AI 和Apelin 水平检测对预测淋巴脉管间隙浸润风险的价值研究[J].现代检验医学杂志,2023,38(05):53.[doi:10.3969/j.issn.1671-7414.2023.05.010]
　LIANG Yanru,ZHENG Yu,LI Qian.Value of Preoperative Serum Apo AI and Apelin Levels in Predicting the Risk of Lymph Node Vascular Space Infiltration in Patients with Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2023,38(05):53.[doi:10.3969/j.issn.1671-7414.2023.05.010]

备注/Memo

备注/Memo:
作者简介:李 玲(1981-),女,大学本科,主管技师,主要从事临床免疫学检验与研究,E-mail:huamaomao5678@126.com。
通讯作者:文 勃(1980-),男,大学本科,副主任医师,E-mail:wenboliling@163.com。
更新日期/Last Update: 2018-09-30